Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1475, 2005-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Impact of Biomarkers and Surrogate End Points on Regulatory Approval of New Drugs
Heart Drug, Vol. 2, Iss. 5, 2003-01 ,pp. :
Access to resources
Recommend
A Note on Breast Cancer Trials With pCR-Based Accelerated Approval
Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. :
In response: Surrogate measures should be abandonded
Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. :
Medication use as a surrogate marker of emotional health in long-term cancer survivors
Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. :